Fingerprint
Dive into the research topics of 'Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar
Takashi Yamamura, Brian Weinshenker, Michael R R. Yeaman, Jerome De Seze, Francesco Patti, Patricia Lobo, H. Christian von Büdingen, Xiujing Kou, Kristina Weber, Benjamin Greenberg
Research output: Contribution to journal › Article › peer-review
16
Scopus
citations